October 30, 2020 – Teladoc Health has completed its acquisition of Livongo in a transaction valued at $18.5 billion based on Teladoc’s closing price Aug. 4.
Earlier this week, Teladoc Health reported strong third quarter results and continued confidence in sustained growth.
Last week, Teladoc CEO Jason Gorevic filed a letter with the Securities and Exchange Commission (SEC) stating that four of Livongo’s C-suite executives will leave after the merger is finalized. Those executives are: Livongo CEO Zane Burke, President Jennifer Schneider, MD, CFO Lee Shapiro, and SVP of Business Development Steve Schwartz.
The company said it expects to directly deliver more than 10 million virtual visits this year and has reported an additional three million enabled visits for its health system clients so far in 2020.